Works matching IS 09395555 AND DT 2018 AND VI 97 AND IP 9


Results: 35
    1
    2
    3
    4
    5

    Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.

    Published in:
    2018
    By:
    • Katodritou, Eirini;
    • Kyrtsonis, Marie-Christine;
    • Delimpasi, Sosana;
    • Kyriakou, Despoina;
    • Symeonidis, Argiris;
    • Spanoudakis, Emmanouil;
    • Vasilopoulos, Georgios;
    • Anagnostopoulos, Achilles;
    • Kioumi, Anna;
    • Zikos, Panagiotis;
    • Aktypi, Anthi;
    • Briasoulis, Evangelos;
    • Megalakaki, Aikaterini;
    • Repousis, Panayiotis;
    • Adamopoulos, Ioannis;
    • Gogos, Dimitrios;
    • Kotsopoulou, Maria;
    • Pappa, Vassiliki;
    • Papadaki, Eleni;
    • Fotiou, Despoina
    Publication type:
    journal article
    6

    Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.

    Published in:
    2018
    By:
    • Egle, Alexander;
    • Steurer, Michael;
    • Melchardt, Thomas;
    • Weiss, Lukas;
    • Gassner, Franz Josef;
    • Zaborsky, Nadja;
    • Geisberger, Roland;
    • Catakovic, Kemal;
    • Hartmann, Tanja Nicole;
    • Pleyer, Lisa;
    • Voskova, Daniela;
    • Thaler, Josef;
    • Lang, Alois;
    • Girschikofsky, Michael;
    • Petzer, Andreas;
    • Greil, Richard
    Publication type:
    journal article
    7
    8
    9
    10

    Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.

    Published in:
    2018
    By:
    • Katodritou, Eirini;
    • Kyrtsonis, Marie-Christine;
    • Delimpasi, Sosana;
    • Kyriakou, Despoina;
    • Symeonidis, Argiris;
    • Spanoudakis, Emmanouil;
    • Vasilopoulos, Georgios;
    • Anagnostopoulos, Achilles;
    • Kioumi, Anna;
    • Zikos, Panagiotis;
    • Aktypi, Anthi;
    • Briasoulis, Evangelos;
    • Megalakaki, Aikaterini;
    • Repousis, Panayiotis;
    • Adamopoulos, Ioannis;
    • Gogos, Dimitrios;
    • Kotsopoulou, Maria;
    • Pappa, Vassiliki;
    • Papadaki, Eleni;
    • Fotiou, Despoina
    Publication type:
    journal article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice.

    Published in:
    2018
    By:
    • Breccia, Massimo;
    • Abruzzese, Elisabetta;
    • Castagnetti, Fausto;
    • Bonifacio, Massimiliano;
    • Gangemi, Domenica;
    • Sorà, Federica;
    • Iurlo, Alessandra;
    • Luciano, Luigiana;
    • Gozzini, Antonella;
    • Gentile, Massimo;
    • Bocchia, Monica;
    • Luzi, Debora;
    • Maggi, Alessandro;
    • Sgherza, Nicola;
    • Isidori, Alessandro;
    • Crugnola, Monica;
    • Pregno, Patrizia;
    • Scortechini, Anna Rita;
    • Capodanno, Isabella;
    • Pizzuti, Michele
    Publication type:
    journal article
    23
    24
    25
    26
    27
    28
    29

    Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience.

    Published in:
    2018
    By:
    • Ciochetto, Chiara;
    • Botto, Barbara;
    • Passera, Roberto;
    • Bellò, Marilena;
    • Benevolo, Giulia;
    • Boccomini, Carola;
    • Castellino, Alessia;
    • Chiappella, Annalisa;
    • Freilone, Roberto;
    • Nicolosi, Maura;
    • Orsucci, Lorella;
    • Pecoraro, Clara;
    • Pregno, Patrizia;
    • Bisi, Gianni;
    • Vitolo, Umberto
    Publication type:
    journal article
    30
    31
    32
    33
    34
    35